Gan & Lee is a leading Chinese pharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative therapies for metabolic diseases and other therapeutic areas. With pioneering expertise in insulin production technology, we launched China’s first domestic insulin glargine biosimilar in 2005. Today, we have built a comprehensive pipeline spanning diabetes, broader metabolic disorders, and non-metabolic indications to address unmet medical needs worldwide.

Learn More: www.ganlee.com

Contact with Us: info@ganlee.com